The effect of reduced oxygen partial pressure in inhaled air on the release of bio-active substances in human saliva.
D000109:Acetylcholine / Q000494:pharmacology; D000328:Adult; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001274:Atmospheric Pressure; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000494:pharmacology; D002268:Carboxypeptidases / Q000494:pharmacology; D005260:Female; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D000860:Hypoxia / Q000201:enzymology*; D066298:In Vitro Techniques; D007610:Kallikreins / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D010100:Oxygen; D010313:Partial Pressure; D051381:Rats; D012463:Saliva / Q000201:enzymology*; D012701:Serotonin / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects
D012701:Serotonin; D001285:Atropine; D006632:Histamine; D007611:Aprotinin; D002268:Carboxypeptidases; D007610:Kallikreins; D000109:Acetylcholine; D010100:Oxygen; D001920:Bradykinin; D008784:Methysergide